Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin. 2023

Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital, Sancaktepe, İstanbul.

OBJECTIVE Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin enters the vascular space and gets through to peripheral cholinergic nerve terminals, it may lead to iatrogenic botulism. METHODS We presented a patient who is diagnosed as iatrogenic botulism and treated with antitoxin at the 15th day of the exposure. RESULTS After the antitoxin administration, dramatical response to the treatment was observed. CONCLUSIONS In this report, we want to evaluate a new case of iatrogenic botulism and emphasize the importance of antitoxin administration regardless the timing of the exposure for patients with progressing paralysis.

UI MeSH Term Description Entries
D007049 Iatrogenic Disease Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by a patient during the course of treatment. Hospital-Acquired Condition,Condition, Hospital-Acquired,Conditions, Hospital-Acquired,Disease, Iatrogenic,Diseases, Iatrogenic,Hospital Acquired Condition,Hospital-Acquired Conditions,Iatrogenic Diseases
D001904 Botulinum Antitoxin Antiserum given therapeutically in BOTULISM. Botulism Antitoxin,Trivalent Equine Botulinum Antitoxin,Antitoxin, Botulinum,Antitoxin, Botulism
D001906 Botulism A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208) Botulism, Infantile,Botulism, Toxico-Infectious,Clostridium botulinum Infection,Foodborne Botulism,Infant Botulism,Toxico-Infectious Botulism,Wound Botulism,Botulism, Foodborne,Botulism, Infant,Botulism, Toxico Infectious,Botulism, Wound,Clostridium botulinum Infections,Foodborne Botulisms,Infant Botulisms,Infantile Botulism,Infection, Clostridium botulinum,Toxico Infectious Botulism,Wound Botulisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000992 Antitoxins Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS. Antitoxin
D019274 Botulinum Toxins, Type A A serotype of botulinum toxins that has specificity for cleavage of SYNAPTOSOMAL-ASSOCIATED PROTEIN 25. Botulinum Neurotoxin Type A,Botulinum Toxin A,Botulinum Toxin Type A,Botox,Botulinum A Toxin,Botulinum Neurotoxin A,Clostridium Botulinum Toxin Type A,Clostridium botulinum A Toxin,Meditoxin,Neuronox,Oculinum,Onabotulinumtoxin A,OnabotulinumtoxinA,Vistabel,Vistabex,Neurotoxin A, Botulinum,Toxin A, Botulinum,Toxin, Botulinum A

Related Publications

Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
November 2003, Presse medicale (Paris, France : 1983),
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
February 2013, The Annals of pharmacotherapy,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
October 2023, European journal of neurology,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
May 2010, Clinical neuropharmacology,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
September 1984, The Journal of infectious diseases,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
November 2011, Clinical and vaccine immunology : CVI,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
February 2022, Ugeskrift for laeger,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
November 2010, The Medical journal of Australia,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
December 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Ozge Gonul Oner, and Hasan Can Gudek, and Ozdem Erturk Cetin, and Serkan Demir
January 1968, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!